Genetic testing company 23andMe has stirred controversy after it helped develop a new drug using DNA samples collected from its own clients. As Ross Lord reports, it’s raising ethical questions on what those samples are really being used for and whether the company’s customers will be fairly compensated for the drug’s research.
Global National
DNA testing firm 23andMe used client samples for drug development
More Videos
-
Tourists flock to Manitoba town for peacocks
-
Syrian refugee family traumatized after son murdered in Halifax
-
B.C. backtracking on drug decriminalization spurs advocates’ fears of worsening crisis
-
Cyberattack prompts all London Drugs locations to close temporarily
-
FBI warns Chinese hackers targeted Canadian politicians
-
Gaza protests: McGill Pro-Palestinian demonstrations spread to UBC, uOttawa
You are viewing an Accelerated Mobile Webpage.
View Original Article